Initial results of a phase 1 first-in-human study of cemsidomide (CFT7455), a novel MonoDAC™ degrader, in patients with non-Hodgkin's lymphoma Meeting Abstract
| Authors: | Horwitz, S.; Jain, S.; Soumerai, J. D.; Tees, M. T.; Stuver, R.; Ali, A.; Leahy, L.; Lobbardi, R.; Chu, R.; Hurh, E.; Fiorino, A. S.; Mehta-Shah, N. |
| Abstract Title: | Initial results of a phase 1 first-in-human study of cemsidomide (CFT7455), a novel MonoDAC™ degrader, in patients with non-Hodgkin's lymphoma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 467 |
| End Page: | 468 |
| Language: | English |
| ACCESSION: | WOS:001415654100017 |
| DOI: | 10.1182/blood-2024-210482 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
